The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Psychophysical Aspects of Hidradenitis Suppurativa
Open accessAbstract
Hidradenitis suppurativa is a recurrent, debilitating suppurative skin disease. The symptoms are much more than just physical, but studies of its impact on patients' psychological state and related quality of life are very limited. The current study was conducted with a group of 54 patients, aged 16-65 years, who had an active, but stable, course of hidradenitis suppurativa. The aim of the study was to determine the influence of hidradenitis suppurativa on a broad spectrum of psychophysical factors. Assessment was carried out using several questionnaires, which revealed the following mean scores: Dermatology Life Quality Index (DLQI) (12.67 +/- 7.7), Beck Depression Inventory-Short Form (BDI-SF) (5.87 +/- 4.68), Evers et al. "6-Item Scale" (3.87 +/- 3.65), EQ-5D (0.66 +/- 0.23 (health index) and 56.78 +/- 18.84 (VAS)), Functional Assessment of Chronic Illness Therapy - Fatigue scale (FACIT-F) (32.06 +/- 11.01) and Quality of Life Enjoyment and Satisfaction Questionnaire Short Form (Q-LES-Q-SF) (56.44 +/- 15.17%). The results highlight the important impact of hidradenitis suppurativa on a wide spectrum of psychophysical aspects and impairment of related quality of life among patients. Our findings indicate that advancement of the disease seems to be the most important factor negatively influencing patients' well-being (p < 0.01). It is noteworthy that an anogenital location appears to impair the hidradenitis suppurativa patients' quality of life most of all (p < 0.05), but the occurrence of lesions on uncovered skin plays a crucial role in the stigmatization level (p < 0.05).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use
FINLAY, A. Y., & KHAN, G. K. (1994) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1994.tb01167.x · Cited by 5,586
(1993) · PubMed · Cited by 1,900
Tyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(05)67763-x · Cited by 1,069
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
Pickard, A. S., Neary, M. P., & Cella, D. (2007) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-5-70 · Cited by 929
Hongbo, Y., Thomas, C. L., Harrison, M. A., Sam Salek, M., & Finlay, A. Y. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23621.x · Cited by 854
Fatigue in cancer patients compared with fatigue in the general United States population
Cella, D., Lai, J., Chang, C., Peterman, A., & Slavin, M. (2002) · Cancer · doi:10.1002/cncr.10245 · Cited by 841
Quality of life impairment in hidradenitis suppurativa: A study of 61 cases
Wolkenstein, P., Loundou, A., Barrau, K., Auquier, P., & Revuz, J. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.08.061 · Cited by 369
Morbidity in patients with hidradenitis suppurativa
Von Der Werth, J. M., & Jemec, G. B. E. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04137.x · Cited by 344
Furlanetto, L. M., Mendlowicz, M. V., & Romildo Bueno, J. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.12.011 · Cited by 299
Bruera, E., Valero, V., Driver, L., Shen, L., Willey, J., Zhang, T., & Palmer, J. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8506 · Cited by 289
What causes hidradenitis suppurativa?
Ralf Paus, L., Kurzen, H., Kurokawa, I., Jemec, G. B. E., Emtestam, L., Sellheyer, K., Giamarellos-Bourboulis, E. J., Nagy, I., Bechara, F. G., Sartorius, K., et al. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00712.x · Cited by 269
Quantifying the harmful effect of psoriasis on health-related quality of life
Weiss, S. C., Kimball, A. B., Liewehr, D. J., Blauvelt, A., Turner, M. L., & Emanuel, E. J. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.122755 · Cited by 265
Chandran, V., Bhella, S., Schentag, C., & Gladman, D. D. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.065763 · Cited by 224
Shalita, A. R. (2004) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2004.03.012 · Cited by 184
Matusiak, L., Bieniek, A., & Szepietowski, J. (2009) · Acta Dermato Venereologica · doi:10.2340/00015555-0749 · Cited by 172
Self-citationUse of a preference-based measure of health (EQ-5D) in COPD and asthma
Pickard, A. S., Solem, C. T., Jung, E., Patel, S., Stavem, K., & Lee, T. A. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2007.11.016 · Cited by 171
Cusack, C., & Buckley, C. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.07067.x · Cited by 171
Revicki, D., Willian, M. K., Saurat, J.-H., Papp, K. A., Ortonne, J.-P., Sexton, C., & Camez, A. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08236.x · Cited by 168
Hidradenitis suppurativa - characteristics and consequences
Jemec, G. B. E., Heidenheim, M., & Nielsen, N. H. (1996) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1996.tb00145.x · Cited by 145
Atopic Dermatitis: Impact on the Quality of Life of Patients and Their Partners
Misery, L., Finlay, A. Y., Martin, N., Boussetta, S., Nguyen, C., Myon, E., & TAIEB, C. (2007) · Dermatology · doi:10.1159/000104263 · Cited by 142
Klassen, A. F., Newton, J. N., & Mallon, E. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.105507 · Cited by 134
Gladman, D. D., Mease, P. J., Cifaldi, M. A., Perdok, R. J., Sasso, E. H., & Medich, J. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.057901 · Cited by 131
Coping Strategies as Determinants of Quality of Life in Stroke Patients: A Longitudinal Study
Darlington, A., Dippel, D. W. J., Ribbers, G. M., van Balen, R., Passchier, J., & Busschbach, J. J. V. (2007) · Cerebrovascular Diseases · doi:10.1159/000101463 · Cited by 129
Fardet, L., Dupuy, A., Kérob, D., Levy, A., Allez, M., Bégon, E., Bachelez, H., Morel, P., & Lebbé, C. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.07.027 · Cited by 128
Giamarellos‐Bourboulis, E. J., Pelekanou, E., Antonopoulou, A., et al. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08372.x · Cited by 124
Hagell, P., Höglund, A., Reimer, J., Eriksson, B., Knutsson, I., Widner, H., & Cella, D. F. (2006) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2006.05.021 · Cited by 121
Donepezil for Cancer Fatigue: A Double-Blind, Randomized, Placebo-Controlled Trial
Bruera, E. D., Osta, B. E. E., Valero, V., Driver, L., Pei, B.-L., Shen, L. F., Poulter, V. A., & Palmer, J. L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.9231 · Cited by 116
Modelling valuations for health states: the effect of duration
Dolan, P. (1996) · Health Policy · doi:10.1016/0168-8510(96)00853-6 · Cited by 107
Long-term efficacy of a single course of infliximab in hidradenitis suppurativa
Mekkes, J. R., & Bos, J. D. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08332.x · Cited by 105
Treatment of Hidradenitis Suppurativa with Tumour Necrosis Factor-alpha Inhibitors
Haslund, P., Lee, R., & Jemec, G. B. E. (2009) · Acta Dermato Venereologica · doi:10.2340/00015555-0747 · Cited by 102
Lu, Y., Duller, P., van der Valk, P. G. M., & Evers, A. W. M. (2003) · Dermatology and Psychosomatics / Dermatologie und Psychosomatik · doi:10.1159/000073991 · Cited by 90
Handicap in Darier's disease and Hailey-Hailey disease
Harris, A., BURGE, S. M., Dykes, P. J., & Finlay, A. Y. (1996) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1996.d01-1102.x · Cited by 68
Grob, J., Auquier, P., Dreyfus, I., & Ortonne, J. ‐. (2007) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2007.02385.x · Cited by 38
Screening for depressive symptoms in the acute phase of stroke
Kellermann, M., Fekete, I., Gesztelyi, R., Csiba, L., Kollár, J., Sikula, J., & Bereczki, D. (1999) · General Hospital Psychiatry · doi:10.1016/s0163-8343(98)00067-x · Cited by 37
Viala, M., Bhakar, A. L., de la Loge, C., de Velde, H. J. V., Esseltine, D. L., Chang, M., Dhawan, R., & Dubois, D. J. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.10.006 · Cited by 34
THIERS, B. H. (2006) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70051-0 · Cited by 30
Loehrer, P. J. (2007) · Yearbook of Oncology · doi:10.1016/s1040-1741(08)70281-1 · Cited by 15
Cited by
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
Zouboulis, C. C., Desai, N., Emtestam, L., Hunger, R. E., Ioannides, D., Juhász, I., Lapins, J., Matusiak, L., Prens, E. P., Revuz, J., et al. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12966 · Cited by 1,093
Self-citationWhat we know about primary dysmenorrhea today: a critical review
Iacovides, S., Avidon, I., & Baker, F. C. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv039 · Cited by 1,022
Sabat, R., Jemec, G. B. E., Matusiak, Ł., Kimball, A. B., Prens, E., & Wolk, K. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0149-1 · Cited by 573
Self-citationvan der Zee, H. H., de Ruiter, L., van den Broecke, D. G., Dik, W. A., Laman, J. D., & Prens, E. P. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10254.x · Cited by 472
Kimball, A. B., Kerdel, F., Adams, D., Mrowietz, U., Gelfand, J. M., Gniadecki, R., Prens, E. P., Schlessinger, J., Zouboulis, C. C., van der Zee, H. H., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-12-201212180-00004 · Cited by 428
Metadata
- Authors
- Matusiak, Ł., Bieniek, A., & Szepietowski, J.
- Venue
- Acta Dermato Venereologica
- Publisher
- Medical Journals Sweden AB
- Published
- 2010
- Volume
- 90
- Issue
- 3
- Pages
- 264-268
- ISSN
- 0001-5555 (ISSN-L)
- OpenAlex
- W2065828171
- Cited by
- 307
- References
- 38
- FWCI
- 7.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.